ADMP inhibitors represent a specialized class of chemical compounds that target and modulate the activity of the protein ADMP (Anti-Dorsalizing Morphogenetic Protein), a member of the TGF-beta superfamily. This protein is involved in complex biochemical pathways, particularly in the regulation of developmental processes. By interacting with ADMP, these inhibitors are able to impact specific cellular signaling mechanisms, particularly those associated with morphogenetic gradients and developmental patterning. The intricate role of ADMP in modulating the balance between various growth factors like BMP (Bone Morphogenetic Protein) and other signaling molecules makes ADMP inhibitors valuable tools for investigating developmental biology and embryogenesis. They serve as molecular probes to delineate how ADMP exerts its effects on different developmental axes, such as the dorsal-ventral axis in vertebrates.
Chemically, ADMP inhibitors are diverse, often characterized by their ability to bind specific active sites or regulatory domains on the ADMP molecule. This binding disrupts the protein's interactions with other components of morphogenetic signaling pathways, thereby influencing cellular differentiation, proliferation, and apoptosis during critical stages of development. The structural diversity of ADMP inhibitors often includes small molecules or peptidomimetics that are engineered for high affinity and specificity to ADMP's active regions. Detailed biochemical studies of these inhibitors have provided insights into the conformational changes and molecular interactions necessary for ADMP's regulatory function. By inhibiting ADMP activity, these compounds offer a method to control or observe changes in the signaling dynamics that underlie the formation of complex tissue structures and patterning during development.
VER TAMBIÉN ....
| Nombre del producto | NÚMERO DE CAS # | Número de catálogo | Cantidad | Precio | MENCIONES | Clasificación |
|---|---|---|---|---|---|---|
4-(6-(4-(Piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline | 1062368-24-4 | sc-476297 | 5 mg | $240.00 | ||
Pequeña molécula inhibidora de los receptores BMP de tipo I, que puede afectar a la señalización relacionada con ADMP. | ||||||
DMH-1 | 1206711-16-1 | sc-361171 sc-361171B sc-361171A sc-361171C | 10 mg 25 mg 50 mg 100 mg | $209.00 $312.00 $620.00 $1026.00 | 2 | |
Inhibidor selectivo del receptor de BMP, podría afectar a las vías de señalización en las que interviene ADMP. | ||||||
Dorsomorphin dihydrochloride | 1219168-18-9 | sc-361173 sc-361173A | 10 mg 50 mg | $182.00 $736.00 | 28 | |
Inhibe la señalización BMP dirigiéndose a los receptores BMP de tipo I, influyendo potencialmente en la actividad ADMP. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $80.00 $212.00 $408.00 | 48 | |
Inhibe las quinasas similares a receptores de activina de tipo I de la superfamilia TGF-β, puede afectar a procesos relacionados con ADMP. | ||||||
SB-505124 | 694433-59-5 | sc-362794 sc-362794A | 10 mg 50 mg | $321.00 $1350.00 | 2 | |
Inhibe ALK4, ALK5, y ALK7, parte de la señalización TGF-β, impactando potencialmente en la función ADMP. | ||||||
A 83-01 | 909910-43-6 | sc-203791 sc-203791A | 10 mg 50 mg | $198.00 $650.00 | 16 | |
Inhibe ALK5, ALK4 y ALK7, puede afectar indirectamente a las vías que implican ADMP. | ||||||
ALK5 Inhibitor II | 446859-33-2 | sc-221234 sc-221234A sc-221234B sc-221234C sc-221234D sc-221234E sc-221234F | 1 mg 5 mg 10 mg 50 mg 100 mg 500 mg 1 g | $75.00 $150.00 $215.00 $650.00 $1224.00 $4296.00 $7818.00 | 8 | |
Inhibe el receptor ALK5 del TGF-β, influyendo potencialmente en la señalización relacionada con ADMP. | ||||||